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OBJECTIVE—High concentrations of circulating glucose are
believed to contribute to defective insulin secretion and -cell
function in diabetes and at least some of this effect appears to be
caused by glucose-induced -cell apoptosis. In mammalian cells,
apoptotic cell death is controlled by the interplay of proapoptotic
and antiapoptotic members of the Bcl-2 family. We investigated
the apoptotic pathway induced in mouse pancreatic islet cells
after exposure to high concentrations of the reducing sugars
ribose and glucose as a model of -cell death due to long-term
metabolic stress.
RESEARCH DESIGN AND METHODS—Islets isolated from
mice lacking molecules implicated in cell death pathways were
exposed to high concentrations of glucose or ribose. Apoptosis
was measured by analysis of DNA fragmentation and release of
mitochondrial cytochrome c.
RESULTS—Deﬁciency of interleukin-1 receptors or Fas did not
diminish apoptosis, making involvement of inﬂammatory cyto-
kine receptor or death receptor signaling in glucose-induced
apoptosis unlikely. In contrast, overexpression of the prosurvival
protein Bcl-2 or deﬁciency of the apoptosis initiating BH3-only
proteins Bim or Puma, or the downstream apoptosis effector
Bax, markedly reduced glucose- or ribose-induced killing of
islets. Loss of other BH3-only proteins Bid or Noxa, or the
Bax-related effector Bak, had no impact on glucose-induced
apoptosis.
CONCLUSIONS—These results implicate the Bcl-2 regulated
apoptotic pathway in glucose-induced islet cell killing and indi-
cate points in the pathway at which interventional strategies can
be designed. Diabetes 59:644–652, 2010
T
ype 2 diabetes develops when insulin-resistant
subjects develop pancreatic -cell dysfunction
(1–3). Progressive -cell dysfunction results in
insufﬁcient insulin secretion to compensate for
insulin resistance. The relative contribution of a decrease
in -cell mass versus a functional defect in insulin secre-
tion toward the overall morbidity remains unclear. Using
human pancreatic tissue from autopsies, Butler et al.
showed that there was an 60% reduction in -cell mass in
type 2 diabetic patients compared with nondiabetic con-
trol subjects, and this was attributed to a 10-fold or
threefold increase in -cell apoptosis in type 2 diabetic
patients who were lean or obese, respectively (4). Al-
though the cause of this apoptosis is not yet clear, glucose,
saturated fatty acids, islet amyloid polypeptides, and in-
terleukin (IL)-1 have all been implicated, and these
molecules are toxic to -cells and -cell lines in vitro.
High concentrations of glucose can cause -cell apopto-
sis and, in addition to a potential role in -cell dysfunction
in type 2 diabetes (2), high circulating glucose concentra-
tions may also contribute to destruction of the remaining
-cells at the time of diagnosis of type 1 diabetes or when
the -cell mass in an islet transplant is marginal. -cell
apoptosis attributed to glucose toxicity has been observed
in several animal models of type 2 diabetes including the
Psammomys obesus desert gerbil (5), the Zucker diabetic
fatty rat (6), and the domestic cat (7). Isolated islets from
P. obesus are susceptible to glucose-dependent DNA frag-
mentation (5).
Several mechanisms for glucose-induced islet toxicity
have been proposed. In human islets, it has been suggested
that glucose induces intraislet production of IL-1, leading
to nuclear factor-B activation, Fas upregulation, and
-cell apoptosis as a consequence of engagement by Fas
ligand (FasL), expressed on neighboring -cells (8–10).
However, these ﬁndings could not be reproduced in other
studies (11,12), leading to alternative mechanisms being
suggested. -cells are vulnerable to endoplasmic reticulum
(ER) stress due to their enormous demand to synthesize
and secrete insulin, and high glucose levels may exacer-
bate this (reviewed in [13]). High concentrations of reduc-
ing sugars were also reported to induce intracellular
peroxides that elicit -cell death (14). The expression of
intrinsic antioxidant enzymes is normally quite low in
-cells (15), and adenoviral overexpression of Gpx-1 pre-
vented glucose-induced apoptosis (14). Glucose induced
expression of the proapoptotic factor thioredoxin-inter-
acting protein, which inhibits the redox-active protein
thioredoxin and, when overexpressed, induces caspase
3–dependent -cell apoptosis (16). Glucose also pro-
moted degradation of cyclic AMP-responsive element
binding protein (CREB) by the ubiquitin-proteasome
pathway leading to -cell apoptosis (17).
In mammalian cells, two distinct pathways control apopto-
sis, the “death receptor” (also called extrinsic) and the
“mitochondrial” (also called intrinsic or Bcl-2 regulated)
pathways. In the intrinsic pathway, the eight BH3-only
proteins (Bim, Bid, Bad, Puma, Noxa, Hrk, Bik, and Bmf)
initiate apoptosis signaling by binding to the Bcl-2–like
prosurvival proteins (Bcl-2, Bcl-xL, Bcl-w, Mcl-1, and A1),
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mitochondrial outer membrane potential, cytochrome c
release, and activation of the caspase cascade (18). Direct
activation of Bax and/or Bak by certain BH3-only proteins
has also been proposed (19). Exposure of human islets to
16.5 mmol/l glucose in vitro for 5 days resulted in upregu-
lation of Bid and Bad and downregulation of Bcl-xL,
resulting in the death of -cells (20). We have shown that
Bid deﬁciency prevents FasL–induced -cell apoptosis
(21), whereas Bcl-2 overexpression protects -cells from a
range of apoptotic stimuli including treatment with proin-
ﬂammatory cytokines, FasL, or staurosporine (21,22).
Mice deﬁcient in Bad were shown to have impaired
glucose homeostasis due to defective insulin secretion in
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FIG. 1. High concentrations of glucose or ribose induce DNA fragmentation, cytochrome c release, and caspase activation in islets. Islets
(100–200) from wild-type mice were cultured in complete medium containing 5.5 mmol/l D-glucose (control) or were exposed to 33.3 mmol/l D-or
L-glucose or 50 mmol/l D-or L-ribose. A: DNA fragmentation was measured by ﬂow cytometry after culture for 6 days in glucose or 4 days in ribose.
i: Representative FACS proﬁles are shown. ii: Data represent islets from a minimum of ﬁve individual mice per group. Statistical signiﬁcance:
*P < 0.0001 compared with control (one-way ANOVA). B: Cytochrome c release was measured by ﬂow cytometry after 4 days of incubation in
control medium or in glucose, or 3 days in ribose. i: Representative FACS proﬁles are shown. ii: Data represent islets from 4–8 individual mice
per group. Statistical signiﬁcance: *P < 0.0001 **P < 0.01 compared with control (one-way ANOVA). C: DNA fragmentation of islet cells after
incubation for (i) 4 days in ribose or (ii) 6 days in glucose in the presence or absence of the caspase inhibitor qVD.oph was measured by ﬂow
cytometry. Data represent islets from 4–5 individual mice per group. Statistical signiﬁcance: *P < 0.0001 compared with ribose or glucose
treatment (one-way ANOVA).
TABLE 1
PCR primers used for gene expression analysis
Gene Sense (5’–3’) Antisense (5’–3’)
bak CTCTCATCGGAGATGATATTAACCG AGTATGATATCAGCCAAAAAGCAGG
bax GGAGATGAACTGGATAGCAATATGG GTTTGCTAGCAAAGTAGAAGAGGGC
bim GAGTTGTGACAAGTCAACACAAACC GAAGATAAAGCGTAACAGTTGTAAGATAACC
puma ATGCCTGCCTCACCTTCATCT AGCACAGGATTCACAGTCTGGA
actin TATTGGCAACGAGCGGTTC CCATACCCAAGAAGGAAGGCT
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to abnormalities in -cell apoptosis. Bim is transcription-
ally upregulated by C/EBP homologous protein (CHOP)
and required for ER stress–induced apoptosis in a range of
cell types (24). Puma has also been implicated in ER
stress–induced apoptosis in certain cell types (25). The
requirement for these molecules has not yet been exam-
ined in -cells.
Understanding how glucose toxicity triggers islet cell
apoptosis is likely to shed new light on mechanisms of
-cell loss in diabetes and may therefore pave the way to
improved therapeutic intervention. We have investigated
the pathways of apoptosis induced in islet cells by high
concentrations of reducing sugars. We found that IL-1
receptor (IL-1R) and Fas are dispensable for this process,
as was Bid, which we have shown is required for extrinsic
pathway apoptosis in islet cells. In contrast, Bcl-2 overex-
pression, loss of the BH3-only proteins Bim or Puma, or
loss of the multi-BH domain protein Bax markedly pro-
tected islets from glucose toxicity.
RESEARCH DESIGN AND METHODS
IL-1R–deﬁcient mice, generated on a mixed C57BL/6129SV background
(using 129SV-derived embryonic stem [ES] cells), were obtained from Dr. M.
Labow (Roche) and backcrossed onto the C57BL/6 genetic background for
eight generations (26). C57BL/6 mice and Fas-deﬁcient Fas
lpr/lpr mice on a
C57BL/6 genetic background were obtained from the Walter and Eliza Hall
Institute animal breeding facility (Kew, Victoria, Australia). Mice globally
deﬁcient for bim, puma, noxa, bid, bax,o rbak have been previously
described (27–31). Mice deﬁcient for puma, noxa,o rbid were generated on an
inbred C57BL/6 background using C57BL/6-derived ES cells. Mice deﬁcient for
bim, bax,o rbak were originally generated on a mixed C57BL/6129SV
genetic background using 129SV-derived ES cells and were backcrossed for
10 generations onto the C57BL/6 background. H-2
bm1 RIP-Bcl-2 transgenic
mice, which express human Bcl-2 in -cells under control of the rat insulin
promoter, have previously been described (22). All animal experiments were
approved by the institutional animal ethics committee.
Reagents. D-glucose and L-glucose (used at 33.3 mmol/l) and D-ribose and
L-ribose (used at 50 mmol/l) were purchased from Invitrogen (Gibco products
Invitrogen, Grand Island, NY) and Sigma-Aldrich (St Louis, MO), respectively.
The concentration of D-glucose or D-ribose and the time of incubation were
titrated to determine optimal culture conditions. The concentrations we used
were similar to those used in previously published reports (9,14,32). The
pan-caspase inhibitor qVD.oph (Enzyme Systems Products, Livermore, CA)
was used at 50 mol/l. Recombinant murine -interferon (IFN) was obtained
from Genentech (San Francisco, CA) and used at 100 units/ml. Human
recombinant interleukin-1 from R&D Systems (Minneapolis, MN) was used
at 150 units/ml.
Preparation of islets. Islets of Langerhans were isolated by collagenase P
(dissolved in Hanks’ balanced salt solution containing 2 mmol/l Ca
2 and 20
mmol/l HEPES) digestion and density gradient centrifugation as described
previously (33). Islets were washed, hand-picked, and cultured overnight at
37°C in 5% CO2 in CMRL medium-1066 (Gibco products Invitrogen) supple-
mented with 100 units/ml penicillin, 100 g/ml streptomycin, 2 mmol/l
glutamine, and 10% FCS (JRH Biosciences, Lenexa, KS) (referred to below as
complete CMRL). We did not observe any differences in number or size of
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FIG. 2. IL-1R or Fas is not required for glucose- or ribose-induced islet cell apoptosis. A: Islets (200) from wild-type, IL-1R
/, Fas
lpr/lpr,o rbid
/
mice were cultured for 6 days in control medium or medium containing 33.3 mmol/l glucose or for 4 days in medium containing 50 mmol/l ribose.
DNA fragmentation was measured by ﬂow cytometry. No signiﬁcant differences were observed among mice of the different genotypes; P  0.1403
(one-way ANOVA). Data are representative of at least three independent experiments using a minimum of three individual mice of each genotype.
B–D: Islets were cultured for 7 days in control medium or 33.3 mmol/l glucose with cytokines added in the last 4 days. The data in B–D represent
islets from three independent experiments. B: Western blotting for iNOS and -actin as a loading control. C:N O 2 concentration in culture
supernatant was determined. D: DNA fragmentation was measured by ﬂow cytometry. No signiﬁcant difference in NO2 production or DNA
fragmentation was observed between islets cultured with glucose and those cultured with glucose  IFN.
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646 DIABETES, VOL. 59, MARCH 2010 diabetes.diabetesjournals.orgislets isolated from mice deﬁcient in Bcl-2 family genes, suggesting that at a
global level, deﬁciency of these genes does not affect islet development (data
not shown).
DNA fragmentation assay. Uniformly sized islets (excluding very large or
necrotic islets) were handpicked into 3.5-cm Petri dishes containing 1.1 ml of
complete CMRL. Islets were then cultured with the appropriate stimuli to
induce apoptosis. At the end of the culture period, nonattached cells and islets
were transferred into polypropylene tubes and washed in PBS. Islets were
then dispersed with trypsin (0.1 mg/ml bovine trypsin [Calbiochem] and 2
mmol/l EDTA in PBS) for 5 min at 37°C. Islets were mechanically dispersed
using a pipette, washed in PBS, and allowed to recover in complete CMRL
medium for1ha t37°C in 5% CO2. Cells were then washed in PBS and
resuspended in 250 l of hypotonic buffer containing 50 g/ml propidium
iodide (Sigma-Aldrich), 0.1% sodium citrate, and 0.1% Triton X-100, which
stains nuclear DNA. The cells were then analyzed on a FACSCalibur (Becton
Dickinson, Franklin Lakes, NJ) using the FL3 channel. Cells undergoing
apoptosis were identiﬁed by their apparent subdiploid DNA content as
previously described (34).
Cytochrome c release assay. Islets were dispersed into single cells using
trypsin, and cytochrome c release was measured using the method previously
described (35). Brieﬂy, cells were permeabilized in 100 l digitonin buffer (80
mmol/l KCl, 50 ng/ml digitonin, and 1 mmol/l EDTA in PBS) for 2 min on ice.
Permeabilized cells were ﬁxed with 4% paraformaldehyde in PBS for 20 min at
room temperature, washed in PBS, and incubated in blocking buffer (3% BSA
and 0.05% saponin in PBS) for 1 h. Cells were then stained overnight at 4°C
with mouse anti–cytochrome c antibody (clone 6H2B4; BD Pharmingen)
followed by staining with phycoerythrin-conjugated sheep anti-mouse IgG
antibodies (Silenus Laboratories, Hawthorn, Australia) in blocking buffer for
1 h at room temperature. Cells were analyzed on a FACSCalibur. The control
samples had a typical background between 5 and 10% cytochrome c release.
This is consistent with published reports using this method (35).
Real-time quantitative RT-PCR analysis. RNA was prepared using the
RNeasy Kit (QIAGEN). First-strand cDNA was prepared from 0.1–0.2 g RNA
using the High Capacity RNA-to-cDNA Master Mix (Applied Biosystems).
Real-time PCR was performed using the ABI Prism 7900 (Applied Biosystems)
and the Power SYBR Green PCR Master Mix (Applied Biosystems) in 15-l
reaction volumes. Data analyses were performed with the ﬂuorescence
threshold CT method using actin as an internal control. Quantitative (q)
RT-PCR was performed using the forward and reverse primers in Table 1.
Western blotting. Islets were incubated for 4 days with cytokines and/or 33.3
mmol/l glucose or 50 mmol/l ribose, washed with PBS, and lysed in 10 lo f
lysis buffer (20 mmol/l Tris/HCl [pH 7.4], 135 mmol/l NaCl, 1.5 mmol/l MgCl2,
1 mmol/l EGTA, 1% Triton X-100, 1 protease inhibitor cocktail [Sigma-
Aldrich], and 1 phosphatase inhibitor cocktail [Sigma-Aldrich]). Samples
were separated by SDS-PAGE and transferred to nitrocellulose using standard
procedures. Western blotting was performed with anti-NOS2 antibody (Ab;
Santa Cruz Biotechnology, Santa Cruz, CA), anti-Bim Ab (clone 3C5; Alexis,
Plymouth Meeting, PA), anti-Puma Ab (ProSci, Poway, CA), and anti-actin Ab
(Santa Cruz Biotechnology) followed by horseradish peroxidase–conjugated
secondary antibodies (Silenus Laboratories) and detection with ECL Western
blotting detection system (GE Healthcare).
Nitrite determination. Nitrite was detected in the cultures by mixing 100 l
supernatant with 100 l Griess reagent (36). Absorbances were read at 540
nm, and nitrite concentrations were calculated using a sodium nitrite standard
curve.
Statistical analysis. Statistical analyses of data were performed using
GraphPad Prism (GraphPad Software, San Diego, CA). All data shown as bar
graphs are represented as means 	 SEM. Data were analyzed by one-way or
two-way ANOVA with Bonferroni post test for comparison of multiple
columns, or by two-tailed paired t tests.
RESULTS
Abnormally high concentrations of glucose or ribose
induce DNA fragmentation in islet cells. Islets from
wild-type C57BL/6 mice were exposed to 33.3 mmol/l
glucose or 50 mmol/l ribose in vitro, and DNA fragmenta-
tion was examined by ﬂuorescence-activated cell sorter
(FACS) analysis as a measure of apoptosis. Wild-type
islets cultured in high concentrations of D-glucose for 6
days displayed a signiﬁcant increase in DNA fragmentation
compared with islets cultured in medium containing only
5.6 mmol/l glucose (Fig. 1A), or those cultured in medium
with 33.3 mmol/l L-glucose (osmolarity control). D-Ribose
mimics the effects of glucose exposure (14), and it killed
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FIG. 3. Bcl-2 overexpression protects islets from glucose- or ribose-
induced apoptosis. Islets (100) from wild-type or RIP.Bcl-2 transgenic
mice were cultured in control medium or medium containing 50 mmol/l
ribose or 33.3 mmol/l glucose. A: Cytochrome c release was measured
by ﬂow cytometry after 3 days of culture. Data represent islets from
ﬁve individual mice per genotype. Statistical signiﬁcance: *P < 0.0001
compared with wild-type islets in 50 mmol/l ribose (one-way ANOVA).
B: DNA fragmentation was measured by ﬂow cytometry after culture
for 4 days with 50 mmol/l ribose. Data represent islets from 5–7
individual mice per genotype. Statistical signiﬁcance: **P < 0.001
compared with wild-type islets in 50 mmol/l ribose (one-way ANOVA).
C: Cytochrome c release was measured by ﬂow cytometry after 4 days
of culture. Data represent islets from four individual mice per geno-
type. Statistical signiﬁcance: *P < 0.0001 compared with wild-type
islets in 33.3 mmol/l glucose (one-way ANOVA). D: DNA fragmentation
was measured by ﬂow cytometry after 6-day culture in 33.3 mmol/l
glucose. Data represents islets from 4–6 individual mice per genotype.
Statistical signiﬁcance: #P < 0.01 compared with wild-type islets in
33.3 mmol/l glucose (one-way ANOVA).
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glucose (Fig. 1A).
To conﬁrm that glucose toxicity triggered apoptosis in
islet cells, we examined release of cytochrome c from the
mitochondria, an event that occurs upstream of internu-
cleosomal DNA fragmentation. High glucose concentrations
promoted release of cytochrome c from the mitochondria
(Fig. 1B). Consistent with the analysis of DNA fragmenta-
tion, high concentrations of ribose triggered mitochondrial
cytochrome c release more rapidly and to a greater extent
than treatment with glucose (Fig. 1B). The pan-caspase
inhibitor qVD.oph signiﬁcantly inhibited ribose-induced
islet cell DNA fragmentation (Fig. 1C), conﬁrming that cell
killing occurred through a caspase-dependent apoptotic
process.
Islets deﬁcient in IL-1 receptors or Fas are not
protected from glucose-induced DNA fragmentation.
Previous studies have suggested that high glucose concen-
trations result in IL-1 production by -cells, leading to
Fas upregulation and autocrine or paracrine FasL-Fas–
induced apoptosis signaling (9,10). To determine the con-
tribution of this proposed cell death pathway to glucose-
induced -cell killing, DNA fragmentation was examined
in islets from mice lacking IL-1 receptors (IL-1R

/
)o r
functional Fas (Fas
lpr/lpr). In response to culture in 50
mmol/l ribose or 33.3 mmol/l glucose, DNA fragmentation
was comparable among islets from wild-type, IL-1R

/
,o r
Fas
lpr/lpr mice (Fig. 2A). In addition, loss of the BH3-only
protein Bid, which we have shown to be essential for
death receptor–mediated islet cell apoptosis (21), also
failed to protect islets from ribose or glucose toxicity (Fig.
2A). These results suggest that IL-1R and Fas are not
involved in glucose/ribose-induced killing of murine islets.
Incubation of mouse islets with recombinant IL-1 and
IFN leads to the induction of inducible nitric oxide
synthase (iNOS) expression, NO2 production, and DNA
fragmentation. If high concentrations of glucose induce
functional concentrations of intraislet IL-1 production,
then these downstream effects should be measurable.
Therefore, we tested whether 33.3 mmol/l glucose together
with IFN could induce iNOS expression, NO2 production,
and DNA fragmentation. Our results show that although
recombinant IL-1 and IFN were able to induce iNOS
expression, as well as a signiﬁcant increase in NO2 pro-
duction and DNA fragmentation, no iNOS expression, NO2
production, or DNA fragmentation was observed in islets
cultured in 33.3 mmol/l glucose in the presence of IFN
(Fig. 2B–D). Together these data rule out a role for IL-1 in
glucose toxicity of mouse islets.
Bcl-2 overexpression protects islet cells from glucose
or ribose toxicity–induced cytochrome c release and
DNA fragmentation. Disruption of the mitochondria and
release of cytochrome c are controlled by the Bcl-2 family
of proteins (37). Therefore, if cytochrome c release
represents a critical point in toxicity of islets to high
concentrations of ribose or glucose, overexpression of
prosurvival Bcl-2 family members, such as Bcl-2 itself,
should inhibit this apoptotic pathway. We therefore
treated islets overexpressing Bcl-2 in -cells and control
islets from nontransgenic animals with high concentra-
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FIG. 4. Loss of Bax but not loss of Bak protects islet cells from ribose-
or glucose-induced cytochrome c release and DNA fragmentation.
Islets (100) from wild-type, bak
/,o rbax
/ mice were cultured in
control medium or medium containing 50 mmol/l ribose or 33.3 mmol/l
glucose. A: Cytochrome c release was measured by ﬂow cytometry after
3 days of culture in ribose. Data represent islets from three individual
mice per genotype. Statistical signiﬁcance: *P < 0.0001 compared with
wild-type islets in 50 mmol/l ribose (one-way ANOVA). B: DNA frag-
mentation was measured by ﬂow cytometry after 4 days of culture in
ribose. Data represent islets from six individual mice per genotype.
Statistical signiﬁcance: *P < 0.0001 compared with wild-type islets in
50 mmol/l ribose (one-way ANOVA). C: Cytochrome c release was
measured by ﬂow cytometry after 4 days of culture in glucose. Data
represent islets from four individual mice per genotype. Statistical
signiﬁcance: *P < 0.0001 compared with wild-type islets in 33.3 mmol/l
glucose (one-way ANOVA). D: DNA fragmentation was measured by
ﬂow cytometry after 6-day culture in glucose. Data represent islets
from three individual mice per genotype. Statistical signiﬁcance: **P <
0.001 compared with wild-type islets in 33.3 mmol/l glucose (one-way
ANOVA).
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ity to apoptosis. Indeed, overexpression of Bcl-2 reduced
cytochrome c release from the mitochondria and signiﬁ-
cantly inhibited DNA fragmentation triggered by exposure
to 50 mmol/l ribose (Fig. 3A and B). Similarly, overexpres-
sion of Bcl-2 substantially reduced cytochrome c release
and DNA fragmentation in islets cultured in medium
containing 33.3 mmol/l glucose (Fig. 3C and D).
Loss of Bax but not Bak protects islets from
glucose- or ribose-induced DNA fragmentation. The
multi-BH domain proapoptotic Bcl-2 family members Bax
and Bak are essential for mitochondrial outer membrane
permeabilization during apoptosis signaling and play es-
sential and in many cell types overlapping roles in the
activation of the execution phase of apoptosis (30). We
tested whether loss of either of these proteins would
result in protection from high concentrations of
ribose or glucose. Bax-deﬁcient islets were resistant to
ribose- or glucose-induced cytochrome c release and
DNA fragmentation, whereas islets from Bak-deﬁcient
mice were normally sensitive (Fig. 4). This result dem-
onstrates that Bax plays a critical role in glucose- or
ribose-induced islet killing.
Individual loss of the BH3-only proteins Bim or Puma
inhibits glucose or ribose toxicity–induced mitochon-
drial cytochrome c release and DNA fragmentation.
The observation that Bcl-2 overexpression or loss of Bax
protects islet cells from glucose toxicity demonstrated
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and indicated that it is initiated by members of the
BH3-only subgroup of the Bcl-2 family. We therefore
isolated islets from a panel of BH3-only–deﬁcient mice
(Bim

/
, Noxa

/
, Puma

/
,o rB i d

/
) to examine their
sensitivity to glucose or ribose toxicity. Deﬁciency of
either Bim or Puma reduced cytochrome c release (Fig.
5A) and DNA fragmentation (Fig. 5B) from the mitochon-
dria to a similar extent as overexpression of Bcl-2. In
contrast, loss of the BH3-only proteins Noxa or Bid had no
impact (Fig. 5A–C).
BH3-only proteins often cooperate to induce apoptosis;
for example, it has been shown that combined loss of Bim
and Puma protects lymphoid and myeloid cells more
potently against a range of apoptotic stimuli, such as
cytokine deprivation, than loss of either BH3-only protein
alone (38). Because apoptosis induced by ribose or glu-
cose toxicity was only partially inhibited by loss of either
Bim or Puma, we examined the possibility that these
proteins cooperate in glucose-or ribose-mediated apopto-
sis. Remarkably, the extent of apoptosis induced by 50
mmol/l ribose (Fig. 5D) or 33.3 mmol/l glucose (Fig. 5E)i n
islets deﬁcient in both Bim and Puma was not signiﬁcantly
above the background level observed in islets cultured in
control medium, and signiﬁcantly lower than apoptosis
seen in islets lacking only Bim or Puma or those overex-
pressing Bcl-2 (compare Fig. 5B and D). These data
demonstrate that Bim and Puma are both activated and
cause glucose or ribose toxicity–induced apoptosis in islet
cells.
Glucose and ribose toxicity cause upregulation of
Puma and Bax mRNA in islet cells. The ability of ribose
or glucose to induce expression of Bim, Puma, Bax, and
Bak was measured by quantitative RT-PCR. After 48-h
exposure to 50 mmol/l ribose, expression of puma and bax
increased fourfold (Fig. 6A–C). Very low levels of bak were
detectable, and these did not change after exposure to
glucose or ribose (data not shown). Incubation with 5
mol/l thapsigargin, which induces apoptosis of islets
(39), induced a twofold to sevenfold increase in expres-
sion of puma, bax, (Fig. 6A–C) and bak (data not shown),
but not bim. Bim expression remained unchanged, even
though this basal level of bim was clearly sufﬁcient to
cause apoptosis in response to ribose incubation. We used
PCR primers that detect BimL and BimEL, but not BimS,s o
we cannot exclude the possibility that BimS is playing a
role. We also determined protein expression by Western
blotting. Consistent with the qRT-PCR data, we observed
an increase in Puma expression after incubation with 33.3
mmol/l glucose or 50 mmol/l ribose, but no change in Bim
expression or phosphorylation (Fig. 6D). We therefore
surmise that the basal level of Bim, or a modiﬁcation that
is not detectable by Western blotting, is critical for glucose
toxicity–induced killing of -cells.
DISCUSSION
We have exposed pancreatic islets to high concentrations
of glucose or ribose in vitro as a model of the long-term
metabolic stress on -cells observed in insulin resistance
and diabetes. We found conclusive evidence that exces-
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mitochondrial (also called intrinsic or Bcl-2-regulated)
pathway. Glucose or ribose caused release of cytochrome
c and DNA fragmentation that are both hallmarks of
apoptosis mediated by the mitochondrial pathway of cell
death (40). The ability of overexpression of the antiapop-
totic protein Bcl-2 to partially inhibit -cell death conﬁrms
the involvement of this pathway. Altered expression of
Bcl-2 family genes has also been observed after exposure of
human islets to high concentrations of glucose, also impli-
cating the intrinsic pathway in glucose toxicity (17,20).
Mitochondrial outer membrane disruption and effector
caspase activation are initiated by activation of the pro-
apoptotic BH3-only Bcl-2 family members (37,41). BH3-
only family members are activated in a death stimulus–and
cell type–speciﬁc manner, and the ability to group stimuli
that trigger apoptosis by the same pathway may help us to
understand the mechanisms of cellular responses (42). We
found that glucose and ribose toxicity–induced apoptosis
requires the BH3-only proteins Bim and Puma and the
multi-BH domain protein Bax, whereas deﬁciency of other
proapoptotic proteins, including Bid and Bak, had no
impact. In previous studies that examined processes that
have been implicated in -cell apoptosis in type 1 diabetes,
including those triggered by perforin/granzyme B, FasL, and
tumor necrosis factor, the BH3-only protein Bid was required
(21,43). Therefore, glucose and ribose toxicity trigger a
distinct apoptotic cascade in islet cells from that triggered by
either perforin plus granzyme B or death receptor ligation.
This makes it unlikely that high concentrations of glucose kill
murine islet cells by the death receptor pathway or a process
involving IL-1R signaling. Moreover, Bcl-2 overexpression or
caspase inhibition provide minimal protection from cytokine-
mediated islet cell death (44,45). This adds further weight to
the notion that this pathway and glucose toxicity–induced
apoptosis are distinct.
Both the ER stress and oxidative stress pathways have
been associated with the toxic effects of glucose and
ribose on islets (13,46). Both of these stress pathways have
also been reported to activate BH3-only proteins, particu-
larly Bim and Puma, in other cell types. In certain epithe-
lial cells, thymocytes and macrophages, treatment with
thapsigargin or tunicamycin caused ER stress–mediated
apoptosis that required the BH3-only protein Bim (24). In
contrast, in neurons Puma was found to be critical for
apoptosis induced by oxidative or ER stress (25,47). Our
results demonstrate that Bim and Puma have critical
overlapping roles in glucose toxicity–induced killing of
islets. This is reminiscent of the ﬁnding that combined loss
of these two BH3-only proteins protects lymphoid cells
against a range of death stimuli, such as cytokine depriva-
tion, more potently than loss of either alone (38). It is
possible that glucose toxicity induces Bim in islet cells
predominantly by triggering ER stress. In other cell types,
ER stress–induced activation of the transcriptional activa-
tor CHOP activates Bim, which is essential for ER stress–
induced apoptosis (24). Because we found no upregulation
of bim mRNA in islets exposed to high concentrations of
glucose or ribose, we surmise that CHOP may be critical for
the basal level of bim expression. This may relate to the fact
that due to the high demand for protein synthesis and
secretion, -cells are in a constant state of ER stress.
Although we were unable to detect evidence of posttransla-
tional modiﬁcation of Bim by Western blotting, we cannot
exclude the possibility that glucose and ribose toxicity acti-
vate Bim posttranslationally. The mechanisms by which
glucose or ribose toxicity activates Puma are currently not
clear, but they may also involve the ER stress pathway.
Perhaps surprisingly, we found that loss of Bax but not
loss of Bak protects islet cells from glucose toxicity. This
is reminiscent of another study with -cells and one with
neuronal cells, both of which found that Bax but not Bak
is critical for their Myc-induced or oxidative stress–in-
duced apoptosis, respectively, although both proteins are
expressed (47,48). In the case of glucose or ribose toxicity–
induced islet killing, it remains possible that Bak does
cooperate with Bax in this pathway to apoptosis because
loss of Bax afforded considerably less protection than
combined loss of Bim and Puma.
In conclusion, we have shown that high concentrations
of glucose and ribose cause apoptosis mediated by the
mitochondrial pathway in islets. This occurs by speciﬁc
pathways distinct from those involved in cytokine- or
death receptor–mediated apoptosis. There is increasing
evidence that -cell mass and -cell susceptibility to apopto-
sis are key determinants in transition from insulin resistance
to diabetes (49), and in mouse models, blocking islet cell
apoptosis can prevent type 2 diabetes (50,51). Identiﬁcation
of Bim, Puma, and Bax as critical mediators in glucose-
induced -cell killing pinpoints possible targets for therapeu-
tic intervention in this disease.
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